Pamela C Egan, MD^1,2, Aryeh Pelcovits, MD³, Thomas W. Leblanc, MD⁴, Caitlyn Krar, BS^5*, Stephen Donnelly, BS^5*, Lila Rubin, MD^6*, Adam Olszewski, MD^7*, John L Reagan, MD⁸ and Rabin Niroula, MBBS⁷

¹Alpert Medical School of Brown University, Providence, RI
²Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI
³Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
⁴Duke Cancer Institute, Duke University School of Medicine, Durham, NC
⁵Lifespan Cancer Institute, Providence, RI
⁶Department of Medicine, Alpert Medical School of Brown University, Providence, RI
⁷Division of Hematology/Oncology, Warren Alpert Medical School of Brown University, Providence, RI
⁸Division of Hematology/Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI

Ala Almanaseer, BSc#^1*, Benjamin Chin-Yee, MD, FRCPC, MA², Pratibha Bhai, PhD^3,4*, Ian Cheong, BMSc^5*, Alejandro Lazo-Langner, MD, MSc, FRCPC^6,7, Jenny M. Ho, MD^8,9, Michael A. Levy, PhD^4,10*, Alan Stuart, BSc, MLT^4,5*, Hanxin Lin, PhD^4,5*, Ian Chin-Yee, MD, FRCPC^5,6, Bekim Sadikovic, PhD, DABMGG, FACMG^4,5* and Cyrus C. Hsia, MD, BSc, FRCPC^6,11

¹Department of Medicine, Western University, Division of Hematology, London, ON, Canada
²Division of Hematology, Department of Medicine, Schulich School of Medicine, Western University, London, ON, Canada
³London Health Sciences Centre, London, ON, Canada
⁴Molecular Diagnostic Program, London Health Sciences Centre, London, ON, Canada
⁵Department of Pathology & Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
⁶Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
⁷Division of Hematology, Department of Medicine, Western University, London, ON, Canada
⁸London Regional Cancer Centre, London Health Sciences Centre, London, ON, Canada
⁹Western University, Division of Hematology, Department of Medicine, London, Canada
¹⁰Department of Pathology & Laboratory Medicine, Western University, London, ON, Canada
¹¹Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada

Stijn Hentzen, MD^1*, Tomer Meirson^2*, Kelly Koehn, MD³, Aaron M Goodman⁴, Rajshekhar Chakraborty, MBBS⁵, Vinay Prasad^6*, Douglas W. Sborov, MD⁷ and Ghulam Rehman Mohyuddin, MD⁸

¹Department of Internal Medicine, Kansas University Medical Center, Mission, KS
²Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel
³University of Kansas, Kansas City
⁴University of California San Diego Moores Cancer Center, San Diego, CA
⁵Hematology and Oncology, Columbia University Medical Center, New York, NY
⁶University of California San Francisco, San Francisco, CA
⁷Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT
⁸Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT

Omer H Jamy, MD¹, Debra M Wujcik, PhD, RN^2*, William Dudley, PhD^3*, Julie M Scott, MSN^4* and Leah Dudley, BSN^3*

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²Carevive Systems, Inc, Columbia, TN
³Piedmont Research Strategies, Greensboro, NC
⁴Carevive Systems, Inc, FRANKLIN, TN

Renato Centrone, MD^1*, Marcelo Bellesso, MD^2*, Rodrigo Santucci Silva, MD³, Joyce Barreto Marques da Rosa Ferreira^4*, Iohanã Gabriely Costa Oliveira^4*, Luana Correa Travassos^4*, Caroline Jorge Espadas^4*, Tamyres Alves Gomes^4*, Mariana Nascimento Caiaffo Rodrigues^4* and Adelson Alves Silva^5*

¹HEMOMED, SAO PAULO, Brazil
²Instituto Hemomed de Oncologia e Hematologia, São PAULO, SAO PAULO, Brazil
³Instituto Hemomed de Oncologia e Hematologia, Sao Paulo, BRA
⁴Instituto de Ensino e Pesquisa Sao Lucas - IEP Hemomed, Sao Paulo, SP, Brazil
⁵Instituto Hemomed, São Paulo, Brazil

Dillon D. Clancy, BA^1*, Anna C. Revette, PhD^2*, Nupur E. Bahl, BA^1*, Kristi Ho, BA^1*, Brad Manor, PhD^3,4*, Marcia Testa, MPH, MPhil, PhD^5*, Christina M. Dieli-Conwright, PhD, MPH^4,6, Tammy T. Hshieh, MD, MPH^1,4,7*, Jane A. Driver, MD, MPH^4,8,9*, Gregory A. Abel, MD, MPH^1,10 and Clark Dumontier, MD^4,7,11*

¹Dana-Farber Cancer Institute, Boston, MA
²Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, MA
³Hebrew Seniorlife, Roslindale, MA
⁴Harvard Medical School, Boston, MA
⁵Harvard T.H. Chan School of Public Health, Boston, MA
⁶Dana Farber Cancer Institute, Boston, MA
⁷Brigham and Women's Hospital, Boston, MA
⁸Brigham and Women’s Hospital, Division of Aging, Boston, MA
⁹Geriatric Research, Education and Clinical Center and Geriatrics and Extended Care, VA Boston Healthcare System, Boston, MA
¹⁰Center for Bioethics, Harvard Medical School, Boston, MA
¹¹New England Geriatric Research Education and Clinical Center, Boston, MA

Omer H Jamy, MD¹, Nicholas Coombs, PhD, MSTAT^2*, Debra M Wujcik, PhD, RN^3* and Aaron Galaznik, MD⁴

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²Piedmont Research Strategies, Greensboro, NC
³Carevive Systems, Inc, Columbia, TN
⁴Carevive Systems Inc, Boston, MA

James B. Collins IV, PharmD^1*, Michele A. Muir, PharmD^2,3*, Emily Mackler, PharmD^4*, Ashley L. Bryant, PhD, RN, OCN, FAAN⁵, William A. Wood, MD, MPH⁶, Stephanie Wheeler, PhD, MPH^7*, Leah Zullig, PhD, MPH^8*, Jennifer E. Lafata, PhD^9* and Benyam Muluneh, PharmD^10,11

¹Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Raleigh, NC
²Divison of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC
³GlaxoSmithKline, Durham, NC
⁴Clinical Quality Initiatives Michigan Oncology Quality Consortium, Michigan Medicine, Ann Arbor, MI
⁵School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC
⁶University of North Carolina, School of Medicine, Chapel Hill, NC
⁷University of North Carolina, Gillings School of Global Public Health, Chapel Hill, NC
⁸Duke University, School of Medicine, Durham, NC
⁹University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC
¹⁰Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC
¹¹University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Shivani Kapur, MD, Susan Frankki, MS^*, Grace Gehrke^*, Serina Johnson, DNP, RN^* and Benjamin M Parsons, DO

Gundersen Health, La Crosse, WI

Friederike Schmitz, MD^1,2*, Charlotte Neuerburg, MD^1,2*, Martin Schumacher, MD^1,2*, Udo Holtick, MD, PhD^2,3*, Edgar Jost^2,4*, Guido Kobbe, MD^2,5*, Ben-Niklas Bärmann, MD^2,5*, Marie-Therese Schmitz, PhD^6*, Matthias Schmid, PhD^6*, Peter Brossart, MD^1,2, Martin Holderried, MD^7* and Tobias A. W. Holderried, MD^1,2*

¹Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany
²Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, CIO ABCD, Germany
³Department I of Internal Medicine, Department I of Internal Medicine,, University Hospital Cologne, Department I of Internal Medicine,, Cologne, Germany
⁴Department of Internal Medicine IV, Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany
⁵Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
⁶Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany
⁷Department of Quality Management, Medical and Business Development, University Hospital of Tübingen, Tübingen, Germany